ZELTIQ Announces Location and Agenda for 2015 Investor Day
Announces Participation in November 2015 Investor Conferences
(firmenpresse) - PLEASANTON, CA -- (Marketwired) -- 10/21/15 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location and agenda for its 2015 investor and analyst day. The event will be held on November 17, 2015 from 9:30 a.m. ET to 12:00 p.m. ET at the Park Hyatt New York in New York City.
The event will focus on the Company''s growth initiatives, R&D pipeline, and financial outlook. It will also include an interactive physician panel that will provide more insight into the Company''s recently launched CoolMini™ applicator, new product growth opportunities, and its proprietary cooling technology for the potential therapeutic treatment of acne.
ZELTIQ Investor Day
November 17, 2015
9:30 a.m. ET to 12:00 p.m. ET (Registration begins at 9:00 a.m. ET)
Park Hyatt New York - ONYX Room (153 W 57th Street)
The agenda will include:
Executive management presentations on new market opportunities from products such as CoolSmooth PRO™ and CoolMini applicators, as well as the Company''s R&D pipeline, Direct-to-Consumer strategy, and long term financial profile
Physician presentations on the CoolMini applicator and clinical data on the potential treatment of acne through the company''s proprietary cooling technology
Q&A with Executive Management
Interactive Physician Panel with Audience Q&A
ZELTIQ is honored to welcome the following physicians as participants for the event:
Richard Rox Anderson, M.D., A.B.D., -- Massachusetts General Hospital, Boston, MA
Farid Kazem, M.D., A.S.P.S., I.S.A.P.S. -- Kazem Aesthetics, Leimuiden, Netherlands
Grant Stevens, M.D., F.A.C.S. -- Marina Plastic Surgery, Los Angeles, CA
Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in three investor conferences in November 2015.
Stifel 2015 Healthcare Conference
Presentation and One-on-One Meetings
Wednesday, November 18, 2015
New York Palace Hotel, New York, NY
9:30 a.m. ET / 6:30 a.m. PT
Goldman Sachs US Emerging & SMID Cap Growth Conference
Presentation and One-on-One Meetings
Thursday, November 19, 2015
Crown Plaza Times Square, New York, NY
10:10 a.m. ET / 7:10 a.m. PT
Canaccord Genuity Medical Technology and Diagnostics Forum
Presentation and One-on-One Meetings
Thursday, November 19, 2015
Westin New York Grand Central, New York, NY
10:30 a.m. ET / 7:30 a.m. PT
Audio webcasts of the Company''s presentations will be available by visiting the investor relations section of ZELTIQ''s web site at . Replays of the presentations will be available for 90 days.
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ''s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 21.10.2015 - 14:05 Uhr
Sprache: Deutsch
News-ID 1393866
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PLEASANTON, CA
Phone:
Kategorie:
Personal Care & Fitness
Anmerkungen:
Diese Pressemitteilung wurde bisher 137 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZELTIQ Announces Location and Agenda for 2015 Investor Day
"
steht unter der journalistisch-redaktionellen Verantwortung von
ZELTIQ Aesthetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
